Takahashi Hiroshi, Iida Yasuaki, Yokoyama Yuichirou, Hasegawa Keiji, Tsuge Shintaro, Fukutake Katsunori, Nakamura Kazumasa, Wada Akihito
Department of Orthopaedic Surgery, Toho University School of Medicine, Tokyo, Japan.
Spine Surg Relat Res. 2018 Jan 27;2(1):18-22. doi: 10.22603/ssrr.2016-0002. eCollection 2018.
Local application of vancomycin has recently become widely used in spine surgery. However, local application is not included in the indication and has not been approved by the US Food and Drug Administration (FDA). Thus, we searched for reports with "intra wound-vancomycin" and "SSI" as keywords in the MEDLINE database, and investigated the efficacy, problems with use, and future prospects based on these reports. Intrawound vancomycin was described as effective in most of the reports, but was found to have no effect or to aggravate the condition in some reports. A toxic effect on osteoblasts due to a high local concentration was described in some reports, whereas local application was found to be safe in other studies. The amount of vancomycin used and the administration method varied among the reports. Overall, the results suggest that intrawound vancomycin is clinically effective, but this has yet to be established in a randomized controlled trial. There is a need to identify cases that should be selected for this treatment and to investigate the dose and optimum concentration of vancomycin for clinical use.
万古霉素的局部应用最近在脊柱手术中已广泛使用。然而,局部应用并不在适应证范围内,且尚未获得美国食品药品监督管理局(FDA)的批准。因此,我们在MEDLINE数据库中以“伤口内万古霉素”和“手术部位感染(SSI)”为关键词搜索报告,并基于这些报告调查其疗效、使用问题及未来前景。在大多数报告中,伤口内应用万古霉素被描述为有效,但在一些报告中发现其无效或会使病情加重。一些报告中描述了高局部浓度对成骨细胞的毒性作用,而在其他研究中发现局部应用是安全的。各报告中万古霉素的使用量和给药方法各不相同。总体而言,结果表明伤口内应用万古霉素在临床上是有效的,但这一点尚未在随机对照试验中得到证实。有必要确定适合这种治疗的病例,并研究临床使用万古霉素的剂量和最佳浓度。